Loading clinical trials...
Loading clinical trials...
Study to Evaluate the Safety and Reactogenicity of the HIV Vaccine SB732462 in HIV Infected Subjects Aged 18 to 55 Years Old
Conditions
Interventions
HIV Vaccine 732462
Placebo vaccine
Locations
6
Germany
GSK Investigational Site
Erlangen, Bavaria, Germany
GSK Investigational Site
Munich, Bavaria, Germany
GSK Investigational Site
Cologne, North Rhine-Westphalia, Germany
GSK Investigational Site
Berlin, Germany
GSK Investigational Site
Hamburg, Germany
GSK Investigational Site
Hamburg, Germany
Start Date
February 3, 2009
Primary Completion Date
August 18, 2010
Completion Date
August 18, 2010
Last Updated
June 18, 2018
NCT04929028
NCT06741631
NCT06741618
NCT01206920
NCT07167927
NCT07216937
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions